eli lilly glp 1 pipeline Strong to help gain from GLP-1 boom: Hardy A look at the R&D

Janik, M

Michael Brooks, COO Number of Employees: ~21,000 Stage: Private Financial Snapshot: The companys market cap was $3.27 billion as of February 2026

Common Drugs : Semaglutide, Liraglutide, Dulaglutide, and Tirzepatide (dual GIP/GLP-1 agonist)

Some people use it to describe taking a break from medication

Science When developing our products, we analyse the latest findings, studies and trends in the fields of nutrition, supplements and biochemistry

Unfortunately, many individuals are using GLP-1 inhibitors to facilitate weight loss when it isnt medically necessary, exposing them to potential side effects without clear benefits